15(S)-HETE ELISA试剂盒
15(S)-HETE ELISA Kit
Be the first to review this product! Submit a review
|
(13 Publications)
15(S)-HETE ELISA Kit is a competitive ELISA designed to quantify 15(S)-HETE with a sensitivity of 69.21 pg/mL
- Colorimetric competitive ELISA - 450 nm readout - works on any plate reader
- Wide dynamic range - quantifies 78.1 - 20000 pg/ml
- Cited in over 10 publications
查看别名
15(S)-hydroperoxy tetraenoic eicosatetraenoic acid
- cELISA
Supplier Data
Competitive ELISA - 15(S)-HETE ELISA Kit (AB133035)
Representative Standard Curve using ab133035
反应性数据
产品详情
Abcam's 15(S)-HETE in vitro competitive ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the accurate quantitative measurement of 15-hydroxyeicosatetraenoic acid in plasma, serum, urine, tissue culture media and other biological fluids.
A goat anti-rabbit IgG antibody has been precoated onto 96-well plates. Standards or test samples are added to the wells, along with an alkaline phosphatase (AP) conjugated-15(S)-HETE antigen and a polyclonal rabbit antibody specific to 15(S)-HETE. After incubation the excess reagents are washed away. pNpp substrate is added and after a short incubation the enzyme reaction is stopped and the yellow color generated is read at 405 nm. The intensity of the yellow coloration is inversely proportional to the amount of 15(S)-HETE captured in the plate.
15(S)-HETE (15-hydroxyeicosatetraenoic acid) is the major hydroxy derivative of arachidonic acid when acted upon by 15-lipoxygenase (15-LOX). It is also the primary monohydroxy acid synthesized by the lipoxygenase activity of Cyclooxygenase-1. Aspirin-mediated acetylation of the COX-1 enzyme results in 15(R)-HETE. Blood platelets, peripheral leukocytes, vascular smooth muscle and other cell types produce Type-1 15-LOX while prostate, lung, skin and cornea tissues produce Type-2. 15-HETE has been proposed to act as a paracrine regulator of smooth muscle and lung neutrophil recruitment due in part to its incorporation into tracheal epithelium at the sn-2 position of phosphatidylinositol. The phosphoinositol modification in turn is thought to affect signal transduction and the regulation of intracellular calcium. Interleukin-4 has been shown to regulate 15(S)-HETE expression and incorporation into cellular phospholipids. 15(S)-HETE binds to actin and the alpha-subunit of mitochondrial ATP synthase suggesting a more direct method in regulating some physiological activities. Increased levels of 15(S)-HETE are associated with asthma, rhinitis, chronic paranasal sinusitis and rheumatoid arthritis.
Cross Reactivity
| Compound | % Cross Reactivity |
| 15(S)-HETE | 100 |
| 5,15-diHETE | 1 |
| 8,15-diHETE | 1 |
| 13(S)-HODE | 0.6 |
| 5-HETE | 0.1 |
| PGB2 | 0.1 |
| PGD2 | 0.1 |
| PGF2α | 0.1 |
| 12(S)-HETE | <0.05 |
| 12(R)-HETE | <0.05 |
| Arachidonic Acid | <0.05 |
| PGE2 | <0.05 |
| Linoleic Acid | <0.05 |
精确度
回收率
规格
性能和储存信息
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
15(S)-HETE functions as a signaling molecule involved in inflammation and cell growth regulation. It participates in modulating cellular responses including acting on endothelial cells where it influences vascular tone and permeability. 15(S)-HETE is not part of a larger protein complex but it interacts with receptors on the cell surface and intracellular signaling pathways. Its role in inflammatory responses and vascular homeostasis is critical for normal physiological processes.
Pathways
15(S)-HETE contributes significantly to the inflammation and arachidonic acid metabolism pathways. It is closely related to prostaglandin and leukotriene synthesis positioning it as an important player in the regulation of inflammation. Within these pathways it interacts with proteins such as cyclooxygenase enzymes and other lipoxygenase isozymes influencing their activities and the production of other eicosanoids that mediate inflammatory responses.
文献 (13)
Recent publications for all applications. Explore the full list and refine your search
Clinical and translational medicine 15:e70347 PubMed40462502
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biotechnology 67:689-704 PubMed38456959
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 130:526-541 PubMed38182686
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 28:e17983 PubMed38070189
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:548 PubMed35697672
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 22:781 PubMed34594422
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:4220 PubMed34244497
2021
Applications
Unspecified application
Species
Unspecified reactive species
Neuro-oncology 23:2014-2027 PubMed33984142
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 20:122 PubMed32863935
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 43:147-158 PubMed31789401
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com